An advanced class of mesenchymal stem cells associated with strong regenerative outcomes in research and clinical observation — repairing tissue, modulating immunity, and reducing chronic inflammation at the cellular level.
Mesenchymal Stem Cells (MSCs) are multipotent stromal cells that play a central role in tissue repair and immune regulation. The "Next-Generation" designation refers to an advanced manufacturing process that preserves cell potency at a higher standard than conventional preparations.
Administered via targeted delivery methods — intravenous, intrathecal, or localised injection — Next-Gen MSCs work through multiple cellular mechanisms to reduce inflammation, modulate immunity, and stimulate tissue regeneration.
The Next-Gen protocol was developed through the scientific work of Dr. Adas Darinskas and collaborators, using advanced selection and cultivation techniques that aim to preserve cell potency and viability throughout the manufacturing process.
Unlike standard MSC preparations, Next-Gen MSCs are cultivated under strictly controlled conditions that preserve their full regenerative potential. Key cellular mechanisms include:
Cellular microscopy
High-resolution imagery coming soon
What Next-Gen MSC therapy does at the cellular level.
Targets inflammation at the cellular level — one of the root drivers of many chronic conditions.
Calms overactive immunity in autoimmune conditions without broadly suppressing the system.
Stimulates repair of bone, cartilage, nerve, and muscle tissue throughout the body.
Promotes neuroplasticity and neuroprotection in conditions affecting the brain and nervous system.
Enhances wound healing, skin elasticity, and cardiovascular repair through targeted regeneration.
Restores functional capacity and supports long-term vitality — the goal underneath every protocol.
Explored across a broad spectrum of chronic, degenerative, and inflammatory conditions.
Research suggests MSCs may support neurological recovery by modulating inflammation in the central nervous system, promoting neuroplasticity, and offering neuroprotective effects. Areas of ongoing study include:
MSCs have well-documented immunomodulatory properties — they can calm overactive immune responses without broadly suppressing the immune system. This makes them a compelling area of research for conditions where the immune system attacks the body itself, including:
Beyond specific disease categories, MSCs are studied for their ability to repair damaged tissue, modulate systemic inflammation, and support the body's natural regenerative processes. Applications under investigation include:
Research imagery
Lab / clinical photo coming soon
MSC therapy has been documented across thousands of peer-reviewed publications examining safety, efficacy, and mechanism. The Next-Gen protocol used at Innovita Clinic is grounded in ongoing research coordinated through our Vilnius coalition — spanning Reverse Body Time's research arm, Froceth's GMP cellular manufacturing, and Innovita's licensed medical administration.
Explore the ResearchFour coordinated steps from first contact through treatment and follow-up.
Comprehensive Zoom review with the scientific and medical team to evaluate your case.
Personalised MSC protocol developed under scientific direction, in collaboration with the treating medical team.
Administered at Innovita Clinic in Vilnius, Lithuania by expert clinicians in a state-of-the-art facility.
Ongoing monitoring, protocol adjustments, and continued coordination with your medical team.
Client stories and testimonials — coming soon.
We are gathering stories from clients who have completed Next-Gen MSC treatment. Check back soon — or reach out directly to speak with the team about client experiences.
Start the ConversationCellular communication and repair through bioactive vesicles derived from MSCs.
Learn MorePrecision biological signalling for anti-aging, recovery, and optimisation.
Learn MoreHigh-dose intravenous delivery for cellular nutrition and accelerated recovery.
Learn More